Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minodronate vs Alendronate in Postmenopausal Osteoporosis with Low Back Pain
NCT05645289Phase 4Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Jan 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of minodronic acid in postmenopausal osteoporosis, sponsored by Peking University Third Hospital. Status: unknown.
02
Drugs
minodronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT05645289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05645289.